Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Cannonau Corp

Healthcare US CNNC

0.0002USD
-0.0001(33.33%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00020.0003
LowHigh

52 Week Range

-0.0006
LowHigh

Fundamentals

  • Previous Close 0.0003
  • Market Cap0.07M
  • Volume11062
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.63746M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00014M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 0.34M 0.34M -0.08595M -0.14864M -0.08653M
Minority interest - - - - -
Net income 0.34M 0.34M -0.08595M -0.14864M -0.08628M
Selling general administrative 0.02M 0.02M 0.09M 0.15M 0.09M
Selling and marketing expenses - - - - -
Gross profit - 0.00016M 0.00014M 0.00141M 0.00026M
Reconciled depreciation - - - - -
Ebit -0.02440M -0.04880M -0.08595M -0.14864M -0.08679M
Ebitda 0.34M 0.34M -0.08595M -0.14864M -0.08653M
Depreciation and amortization 0.36M 0.02M - - 0.00026M
Non operating income net other - - - - -
Operating income -0.02440M -0.02440M -0.08595M -0.14864M -0.08679M
Other operating expenses 0.02M 0.02M 0.09M 0.15M 0.09M
Interest expense - - - 0.00000M 0.00026M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.02440M - - -0.00026M
Total revenue - 0.00000M 0.00023M 0.00618M 0.00184M
Total operating expenses 0.02M 0.02M 0.09M 0.15M 0.09M
Cost of revenue - -0.00016M 0.00009M 0.00477M 0.00158M
Total other income expense net 0.36M 0.36M - - 0.00026M
Discontinued operations - - - - -
Net income from continuing ops - -0.03431M -0.08595M -0.14864M -0.08653M
Net income applicable to common shares - - -0.08595M -0.14864M -0.08653M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets - 0.00000M 0.00903M 0.00876M 0.02M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab - 0.00000M 0.35M 0.26M 0.17M
Total stockholder equity - 0.00000M -0.33824M -0.25229M -0.14882M
Deferred long term liab - - - - -
Other current liab - - 0.33M 0.24M 0.15M
Common stock 0.24M 0.24M 0.24M 0.24M 0.24M
Capital stock - 0.24M 0.24M 0.24M 0.24M
Retained earnings -3.44993M -3.44993M -3.78817M -3.70222M -3.55358M
Other liab - - 0.00000M - -
Good will - - - - -
Other assets - - - - -
Cash - 0.00000M 0.00016M 0.00014M 0.00016M
Cash and equivalents - - - - -
Total current liabilities - 0.00000M 0.35M 0.26M 0.17M
Current deferred revenue - - - - -
Net debt - - -0.00016M -0.00014M -0.00016M
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 3.21M 3.21M 3.21M 3.21M 3.16M
Property plant equipment - - 0.00903M 0.00876M -
Total current assets - 0.00000M 0.00903M 0.00876M 0.02M
Long term investments - - - - -
Net tangible assets - - -0.33824M -0.25229M -0.14882M
Short term investments - - - - -
Net receivables - 0.00000M 0.00503M 0.00503M -
Long term debt - - - - -
Inventory - 0.00000M 0.00384M 0.00358M 0.02M
Accounts payable - 0.00000M 0.02M 0.02M 0.02M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.03M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - 0.00000M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - 0.00000M 0.00000M 0.00000M 0.00000M
Change to liabilities - - -0.00125M 0.00136M 0.01M
Total cashflows from investing activities - - - - -
Net borrowings - - 0.09M 0.09M 0.08M
Total cash from financing activities - 0.08M 0.09M 0.14M 0.08M
Change to operating activities - - - - -
Net income 0.34M 0.34M -0.08595M -0.14864M -0.08653M
Change in cash -0.00016M -0.00016M 0.00001M -0.00002M 0.00010M
Begin period cash flow 0.00016M 0.00016M 0.00014M 0.00016M 0.00007M
End period cash flow 0.00000M 0.00016M 0.00016M 0.00014M 0.00016M
Total cash from operating activities -0.00016M -0.00016M -0.08745M -0.13672M -0.08063M
Issuance of capital stock - - - 0.05M 0.02M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.00384M 0.00384M -0.00025M 0.02M -0.00813M
Change to account receivables 0.00503M 0.00503M 0.00000M -0.00503M -0.01404M
Sale purchase of stock - - - - -0.00600M
Other cashflows from financing activities - - 0.09M 0.09M 0.07M
Change to netincome - - 0.00000M -0.00000M -0.00000M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.33840M -0.33840M -0.00150M 0.01M 0.00591M
Stock based compensation - - - - -
Other non cash items 0.00000M 0.00000M 0.00000M -0.00000M -
Free cash flow -0.00016M -0.00016M -0.08745M -0.13672M -0.08063M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNNC
Cannonau Corp		 -0.0001 33.33% 0.0002 - - 7226.92 4.18 29730.47 -102.1937
ZTS
Zoetis Inc		 1.26 1.67% 77.16 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Cannonau Corp. engages in the provision of cannabidiol based products. The company was formerly known as Pacific Blue Energy Corp. and changed its name to Cannonau Corp. in August 2019. Cannonau Corp. was incorporated in 2007 and is based in Skaneateles, New York.

Cannonau Corp

937 Old Senecca Turnpike Road, Skaneateles, NY, United States, 13252-9318

Key Executives

Name Title Year Born
Carmen Joseph Carbona CEO, CFO & Director 1963
Mr. Markwin M. Maring CEO, CFO & Director 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions